Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

Human Pathology

Volumn 30, Issue 10, 1999, Pages 1134-1139

  Tsuda, Hitoshi ^a   Takarabe, Teruko ^b   Hasegawa, Tadashi ^b   Murata, Tetsuya ^b   Hirohashi, Setsuo ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NONE

Author keywords

Breast cancer; Central acellular zone; Myoepithelial differentiation

Indexed keywords

ALPHA ACTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KERATIN; PROTEIN S 100;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MYOEPITHELIUM CELL;

EID: 0032882435     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90028-X     Document Type: Article

References (25)

1. Huvos AG, Lucas JC Jr, Foote FW Jr: Metaplastic breast carcinoma: Rare form of mammary cancer. NY Stat J Med 73:1078-1082, 1973
2. Kaufman MW, Marti JR, Gallager HS, et al: Carcinoma of the breast with pseudosarcomatous metaplasia. Cancer 53:1908-1917, 1984
3. Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. HUM PATHOL 20:628-635, 1989
4. Wargotz ES, Deos PH, Norris HJ: Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. HUM PATHOL 20:732-740, 1989
5. Oberman HA: Metaplastic carcinoma of the breast: A clinicopathologic study of 29 patients. Am J Surg Pathol 11:918-929, 1987
6. Hamperl H: The myoepithelia (myoepithelial cells): Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol 53:161-220, 1970
7. Allen AC: So-called mixed tumors of the mammary gland of dog and man, with special reference to the general problem of cartilage and bone formation. Arch Pathol 29:589-624, 1940
8. Meis JM, Ordonez NG, Gallager HS: Sarcomatoid carcinoma of the breast: An immunohistochemical study of six cases. Virchows Arch A 410:415-421, 1987
9. Rosen PP, Oberman HA: Tumors of the mammary gland, in Atlas of Tumor Pathology. Third series, fascicle 7. Washington DC, Armed Forces Institute of Pathology, 1993
10. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377, 1957
11. Tsuda H, Hirohashi S, Shimosato Y, et al: Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma: A retrospective analysis of 176 cases. Cancer 65:1794-1800, 1990
12. Kindblom L-G, Lodding P, Rosengren L, et al: S-100 protein in melanocytic tumors. Acta Pathol Microbiol Immunol Scand Sect A 92:219-230, 1984
13. Haimoto H, Hosoda S, Kato K: Differential distribution of immunoreactive S100-α and S100-β proteins in normal non-nervous human tissues. Lab Invest 57:489-498, 1987
14. Skalli O, Ropraz P, Trzecak A, et al: A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796, 1986
15. Viale G, Gambacorta M, Coggi G, et al: Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast. Virchows Arch A 418:339-348, 1991
16. Wetzels RHW, Holland R, van Haelst UJGM, et al: Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 134:571-579, 1989
17. Iwaya K, Tsuda H, Fukutomi T, et al: Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer. Jpn J Clin Oncol 27:6-12, 1997
18. Dwarakanath S, Lee AKC, Delellis RA, et al: S-100 protein positivity in breast carcinomas: A potential pitfall in diagnostic immunohistochemistry. HUM PATHOL 18:1144-1148, 1987
19. Stroup RM, Pinkus GS: S-100 immunoreactivity in primary and metastatic carcinoma of the breast: A potential source of error in immunodiagnosis. HUM PATHOL 19:949-953, 1988
20. Gillet CE, Bobrow LG, Millis RR: S100 protein in human mammary tissue: Immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and values as a marker of myoepithelial cells. J Pathol 160:19-24, 1990
21. Matsushima S, Mori M, Adachi Y, et al: S100 protein positive human breast carcinomas: An immunohistochemical study. J Surg Oncol 55:108-113, 1994
22. Funahashi H, Koshikawa T, Ichihara S, et al: Different distributions of immunoreactive S100-alpha and S100-beta protein expression in human breast cancer. J Surg Oncol 68:25-29, 1998
23. Santini D, Ceccarelli C, Taffurelli M, et al: Differentiation pathways in primary invasive breast carcinomas as suggested by intermediate filament and biopathological marker expression. J Pathol 179:386-391, 1996
24. Gould VE, Koukoulis GK, Jansson DS, et al: Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 137:1143-1155, 1990
25. Hasebe T, Tsuda H, Tsubono Y, et al: Fibrotic focus in invasive ductal carcinoma of the breast: A histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. Jpn J Cancer Res 88:590-599, 1997